Tirzepatide 20mg

Tirzepatide is a synthetic 39-amino-acid polypeptide designed as a dual GIP/GLP-1 receptor agonist. It incorporates two Aib residues for proteolytic stability and a C20 fatty diacid chain linked via γGlu-2×OEG to a lysine at position 20, enabling prolonged half-life and once-weekly dosing. Research has explored its effects on glucose-dependent insulin secretion, glucagon suppression, gastric emptying, appetite control, glycemic regulation, and body weight reduction in preclinical and clinical models. This 20mg lyophilized preparation is intended strictly for in vitro research and laboratory investigation. Not for human consumption.